LIMD2 and non-small cell lung carcinoma: It appears that miR-34a inhibits NSCLC cell growth by targeting Sirtuin (SIRT) 611, LIM domain containing 2 (LIMD2)12, or programmed death ligand 1 (PD-L1)13, and it also suppresses the invasion of NSCLC cells by targeting LIMD212.